The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Filipino naturopathy practitioner Arturo Arboleda, also known as Doc Atoie, denies endorsing the herbal foot patch that ...

Danish pharmaceutical giant Novo Nordisk is set to lose Canadian patent protection on its popular semaglutide-based drugs, ...

Diabetes is a leading cause of vision loss in the United States, and cataracts are a common complication of the disease. With ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Diabetic neuropathy pain can be effectively managed through a combination of medical treatment, lifestyle changes, and supportive therapies ...

EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...

Researcher says lab tampered with his findings, falsely accused him of sexual harassment; Stanford says investigation found ...

Regenerative medicine is a relatively new field that encompasses multiple sub-specialties including dermatology. As a ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...